Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published June 12, 2007 | Supplemental Material
Journal Article Open

Exhaustive mutagenesis of six secondary active-site residues in Escherichia coli chorismate mutase shows the importance of hydrophobic side chains and a helix N-capping position for stability and catalysis


Secondary active-site residues in enzymes, including hydrophobic amino acids, may contribute to catalysis through critical interactions that position the reacting molecule, organize hydrogen-bonding residues, and define the electrostatic environment of the active site. To ascertain the tolerance of an important model enzyme to mutation of active-site residues that do not directly hydrogen bond with the reacting molecule, all 19 possible amino acid substitutions were investigated in six positions of the engineered chorismate mutase domain of the Escherichia coli chorismate mutase-prephenate dehydratase. The six secondary active-site residues were selected to clarify results of a previous test of computational enzyme design procedures. Five of the positions encode hydrophobic side chains in the wild-type enzyme, and one forms a helix N-capping interaction as well as a salt bridge with a catalytically essential residue. Each mutant was evaluated for its ability to complement an auxotrophic chorismate mutase deletion strain. Kinetic parameters and thermal stabilities were measured for variants with in vivo activity. Altogether, we find that the enzyme tolerated 34% of the 114 possible substitutions, with a few mutations leading to increases in the catalytic efficiency of the enzyme. The results show the importance of secondary amino acid residues in determining enzymatic activity, and they point to strengths and weaknesses in current computational enzyme design procedures.

Additional Information

© 2007 American Chemical Society. Received January 31, 2007; Revised Manuscript Received April 12, 2007, Published on Web 05/17/2007. This work was supported by the Howard Hughes Medical Institute, the Defense Advanced Research Projects Agency, the Institute for Collaborative Biotechnologies (ARO), the Ralph M. Parsons foundation, and an IBM Shared University Research Grant.

Attached Files

Supplemental Material - Mayo_Biochemistry_2007_supp.pdf


Files (46.9 kB)
Name Size Download all
46.9 kB Preview Download

Additional details

August 22, 2023
October 24, 2023